Columbia University, New York, New York, USA.
Institute of Comparative Medicine, Columbia University, New York, New York, USA.
Ultrasound Med Biol. 2020 Oct;46(10):2785-2800. doi: 10.1016/j.ultrasmedbio.2020.06.010. Epub 2020 Jul 27.
Myocardial elastography (ME) is an ultrasound-based strain imaging method that aims to determine the degree of ischemia or infarction as a result of the change in the elastic properties of the myocardium. A survival canine model (n = 11) was employed to investigate the ability of ME to image myocardial infarction formation and recovery. Infarcts were generated by ligation of the left anterior descending coronary artery. Canines were survived and imaged for 4 days (n = 7) or 4 weeks (n = 4), allowing sufficient time for recovery via collateral perfusion. A radial strain-based metric, percentage of healthy myocardium by strain (PHM), was developed as a marker for healthy myocardial tissue. PHM was strongly linearly correlated with actual infarct size as determined by gross pathology (R = 0.80). Mean PHM was reduced 1-3 days post-infarction (p < 0.05) at the papillary and apical short-axis levels; full infarct recovery was achieved by day 28, with mean PHM returning to baseline levels. ME was capable of diagnosing individual myocardial segments as non-infarcted or infarcted with high sensitivity (82%), specificity (92%) and precision (85%) (area under the receiver operating characteristic curve = 0.90). The study therefore strengthens the ME premise that it can detect and assess myocardial infarction progression and recovery in vivo and could thus provide an important role in both disease diagnosis and treatment assesssment.
心肌弹性成像(ME)是一种基于超声的应变成像方法,旨在确定心肌弹性特性变化导致的缺血或梗死程度。采用存活犬模型(n=11)研究 ME 成像心肌梗死形成和恢复的能力。通过结扎左前降支冠状动脉产生梗死。犬存活并在 4 天(n=7)或 4 周(n=4)进行成像,为侧支灌注提供了足够的恢复时间。开发了一种基于径向应变的指标,即应变健康心肌百分比(PHM),作为健康心肌组织的标志物。PHM 与大体病理学确定的实际梗死面积呈强线性相关(R=0.80)。梗死后 1-3 天(p<0.05),乳头肌和心尖短轴水平的 PHM 降低;到第 28 天,完全恢复梗死,PHM 恢复到基线水平。ME 能够以高灵敏度(82%)、特异性(92%)和精度(85%)诊断单个心肌节段是否为非梗死或梗死(接受者操作特征曲线下面积=0.90)。因此,该研究证实了 ME 能够在体内检测和评估心肌梗死的进展和恢复,从而在疾病诊断和治疗评估中可能发挥重要作用。